Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Ochre Bio is a London biotechnology company founded in 2019 that develops RNA medicines for chronic liver disease. It tests candidates on donated human livers kept alive on perfusion machines rather than relying only on animal models. The company partners with pharmaceutical firms on liver-targeted therapeutic programmes.
News
Meet the man trying to eradicate the need for liver transplants
The post Meet the man trying to eradicate the need for liver transplants appeared first on Ochre Bio.
Read more
Report
Why the liver is the body's most misunderstood organ
The post Why the liver is the body's most misunderstood organ appeared first on Ochre Bio.
Read more
Report
How old is YOUR liver? Take our 6-step test to find out if you're at risk of fibrosis and cirrhosis… and the easy lifestyle tweaks to de-age the organ FAST
The post How old is YOUR liver? Take our 6-step test to find out if you're at risk of fibrosis and cirrhosis… and the easy lifestyle tweaks to de-age the organ FAST appeared first on Ochre Bio.
Read more
Report
All the economic wins Keir Starmer wants to bag in China
The post All the economic wins Keir Starmer wants to bag in China appeared first on Ochre Bio.
Read more
Report
Ochre Bio and GSK complete early research into human liver
The post Ochre Bio and GSK complete early research into human liver appeared first on Ochre Bio.
Read more
Report
Pro access
Upgrade to see all 18 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ